BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month

  First Wave BioPharma, Inc., announced that in honor of Celiac Disease Awareness Month in May, it will partner with Celiac Journey, a celiac disease patient advocacy organization, to share an awareness digital display on the Nasdaq Tower in Times Square on Thursday, May 16, at 4:25 p.m. ET.

  May 9, 2024

   · 

  6 min read
• Business

  Applied Therapeutics Reports First Quarter 2024 Financial Results

  Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, reported financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  11 min read
• Genetown

  X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility

  X4 Pharmaceuticals announced that it has completed the sale of its Rare Pediatric Disease Priority Review Voucher to an undisclosed purchaser for $105 million and that it has drawn an additional tranche of $20 million under its existing loan facility with Hercules Capital, Inc.

  May 9, 2024

   · 

  5 min read
• Business

  ProQR Announces First Quarter 2024 Operating and Financial Results

  ProQR Therapeutics NV. reported its financial and operating results for the first quarter ended March 31, 2024, and provided a business update.

  May 9, 2024

   · 

  17 min read
• Drug Development

  Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

  Eledon Pharmaceuticals, Inc. announced that the Company will participate in the American Transplant Congress taking place in Philadelphia, PA from June 1-5, 2024.

  May 9, 2024

   · 

  2 min read
• Business

  Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations

  Merakris Therapeutics announced that Jonathan Berlent has joined the company as Senior Vice President, Head of Strategy and Operations.

  May 9, 2024

   · 

  3 min read